CLINICAL

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
Yusuf Yazici, Jeffrey R Curtis, Akgun Ince, Herbert Baraf, Raymond L Malamet, Lichen L Teng, Arthur Kavanaugh

Annals of the Rheumatic Diseases Feb 2012, 71 (2) 198-205; DOI: 10.1136/ard.2010.148700
Assessment and determinants of aesthetic discomfort in hand osteoarthritis
Bridget Hodkinson, Emmanuel Maheu, Mathilde Michon, Fabrice Carrat, Francis Berenbaum

Annals of the Rheumatic Diseases Jan 2012, 71 (1) 45-49; DOI: 10.1136/ard.2011.153965
Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis
Lihi Eder, Vinod Chandran, Fawnda Pellet, Sutha Shanmugarajah, Cheryl F Rosen, Shelley B Bull, Dafna D Gladman

Annals of the Rheumatic Diseases Jan 2012, 71 (1) 50-55; DOI: 10.1136/ard.2011.155044
Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab
Bimba F Hoyer, Imtiaz M Mumtaz, Konstanze Loddenkemper, Anne Bruns, Claudia Sengler, Kay-Geert Hermann, Sofiane Maza, Rolf Keitzer, Gerd-Rüdiger Burmester, Frank Buttgereit, Andreas Radbruch, Falk Hiepe

Annals of the Rheumatic Diseases Jan 2012, 71 (1) 75-79; DOI: 10.1136/ard.2011.153007
Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis
Paul Emery, Désirée van der Heijde, Mikkel Østergaard, Philip G Conaghan, Mark C Genovese, Edward C Keystone, Roy Fleischmann, Elizabeth C Hsia, Weichun Xu, Stephen Xu, Mahboob U Rahman

Annals of the Rheumatic Diseases Dec 2011, 70 (12) 2126-2130; DOI: 10.1136/ard.2011.154500
Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI
F Gandjbakhch, V Foltz, A Mallet, P Bourgeois, B Fautrel

Annals of the Rheumatic Diseases Dec 2011, 70 (12) 2159-2162; DOI: 10.1136/ard.2010.149377
A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis
Sharon Veenbergen, Miranda B Bennink, Alsya J Affandi, Natacha Bessis, Jérôme Biton, Onno J Arntz, Wim B van den Berg, Fons A J van de Loo

Annals of the Rheumatic Diseases Dec 2011, 70 (12) 2167-2175; DOI: 10.1136/ard.2011.154815
Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus
Maciej Lech, Claudia Kantner, Onkar P Kulkarni, Mi Ryu, Ekaterina Vlasova, Jürgen Heesemann, David Anz, Stefan Endres, Koichi S Kobayashi, Richard A Flavell, Javier Martin, Hans-Joachim Anders

Annals of the Rheumatic Diseases Dec 2011, 70 (12) 2207-2217; DOI: 10.1136/ard.2011.155515
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
Michael Schiff, Mauro Keiserman, Christine Codding, Suthin Songcharoen, Alberto Berman, Sauithree Nayiager, Cristina Saldate, Richard Aranda, Jean-Claude Becker, Marleen Nys, Manuela le Bars, Diane Moniz Reed, Coralie Poncet, Maxime Dougados

Annals of the Rheumatic Diseases Nov 2011, 70 (11) 2003-2007; DOI: 10.1136/annrheumdis-2011-200316
Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's)
F O Henes, Y Chen, TA Bley, M Fabel, M Both, K Herrmann, E Csernok, WL Gross, F Moosig

Annals of the Rheumatic Diseases Nov 2011, 70 (11) 1926-1929; DOI: 10.1136/ard.2010.146456

Main menu

CLINICAL

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CLINICAL

Pages